ScanBalt Opportunities: Perspectives for established Biopharmaread presentation in pdf
Jørgen Dirach MD, MBA
Director
Novo Nordisk A/S

EGeen – A Global ScanBalt Opportunityread presentation in pdf
Kalev Kask, Ph.D. , Chief Executive Officer
AGY Therapeutics, Stanford, advisor to Toshiba, Asper Biotech

ScanBalt: Opportunities in the Baltic Sea Area Through Borderless Biotechread presentation in pdf
Leslie A. Platt, JD
Principal
Ernst & Young LLP
McLean, Virginia, USA

ScanBalt: Opportunities in the Baltic Sea Area Through Borderless Biotechread presentation in pdf
Wolfgang Blank & Heinrich Cuypers
ScanBalt Initiative
BioCon Valley® Initiative

ScanBalt – Borderless Biotechread presentation in pdf
Prof. Bo Samuelsson
Chairman ScanBalt Steering committee
Vice chairman MedCoast Scandinavia steering committee
Vice Chancellor Göteborg University